rs1555597263
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_058216.3(RAD51C):c.705+8T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: not found (cov: 31) 
Consequence
 RAD51C
NM_058216.3 splice_region, intron
NM_058216.3 splice_region, intron
Scores
 2
 Splicing: ADA:  0.0001959  
 2
Clinical Significance
Conservation
 PhyloP100:  0.608  
Publications
0 publications found 
Genes affected
 RAD51C  (HGNC:9820):  (RAD51 paralog C) This gene is a member of the RAD51 family. RAD51 family members are highly similar to bacterial RecA and Saccharomyces cerevisiae Rad51 and are known to be involved in the homologous recombination and repair of DNA. This protein can interact with other RAD51 paralogs and is reported to be important for Holliday junction resolution. Mutations in this gene are associated with Fanconi anemia-like syndrome. This gene is one of four localized to a region of chromosome 17q23 where amplification occurs frequently in breast tumors. Overexpression of the four genes during amplification has been observed and suggests a possible role in tumor progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013] 
RAD51C Gene-Disease associations (from GenCC):
- breast-ovarian cancer, familial, susceptibility to, 3Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Fanconi anemia complementation group OInheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
- hereditary breast ovarian cancer syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57). 
BP6
Variant 17-58703337-T-A is Benign according to our data. Variant chr17-58703337-T-A is described in ClinVar as Likely_benign. ClinVar VariationId is 492380.Status of the report is criteria_provided_single_submitter, 1 stars. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
31
GnomAD4 exome Cov.: 31 
GnomAD4 exome 
Cov.: 
31
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
31
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Hereditary cancer-predisposing syndrome    Benign:1 
Jun 12, 2017
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 dbscSNV1_ADA 
 Benign 
 dbscSNV1_RF 
 Benign 
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.